Letrozole Dose Increments in PCOS Patients Resistant to Letrozole
Status:
COMPLETED
Trial end date:
2024-01-30
Target enrollment:
Participant gender:
Summary
Objectives: To study the effect of Letrozole dose increments on ovulation rate and endometrial thickness as a primary outcomes in patients with polycystic ovary syndrome who previously resistant to letrazole conventional dose, and chemical and clinical pregnancy considered as secondary outcomes.